C. Chattopadhyay

发表

Bronchiectasis and rheumatoid arthritis: a clinical study.

M. McMahon, R. Wolstenholme, D. Swinson, 1993, Annals of the rheumatic diseases.

The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis

J. Lamb, I. Bruce, B. Harrison, 2018, Rheumatology.

GDF5 Polymorphism associated with osteoarthritis: risk for rheumatoid arthritis

E. Urcelay, J. Jover, J. Varadé, 2007, Annals of the rheumatic diseases.

Splenic infarction in a patient with Wegener's granulomatosis.

D. Roy, D. Grennan, C. Chattopadhyay, 1999, Rheumatology.

Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis

W. Dixon, A. Barton, I. Bruce, 2015, Arthritis & rheumatology.

DQw7 and the C4B null allele in rheumatoid arthritis and Felty's syndrome.

C. Kelly, D. Grennan, P. Sanders, 1990, Annals of the rheumatic diseases.

HLA associations in subjects with rheumatoid arthritis and bronchiectasis but not with other pulmonary complications of rheumatoid disease.

R. Cooper, M. McMahon, M. Hillarby, 1993, British journal of rheumatology.

A case of rheumatoid vasculitis involving the gastrointestinal tract in early disease.

B. Parker, C. Chattopadhyay, 2007, Rheumatology.

Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis

S. Tuck, B. Harrison, B. Griffiths, 2022, Rheumatology.

Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

W. Dixon, I. Bruce, Paul Wordsworth, 2013, The Pharmacogenomics Journal.